Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Intervalo de año de publicación
1.
Braz. j. med. biol. res ; 40(1): 19-25, Jan. 2007. ilus, tab
Artículo en Inglés | LILACS | ID: lil-439673

RESUMEN

Lithium has been used for the last five decades to treat bipolar disorder, but the molecular basis of its therapeutic effect is unknown. Phosphoglucomutase is a key enzyme in the metabolism of glycogen. In yeast, rabbit and human HEK293 cells, it is inhibited by lithium in the therapeutic concentration range. We measured the phosphoglucomutase activity in erythrocytes and the inhibitor constant for lithium in a population of healthy subjects and compared them to those of bipolar patients treated with lithium or carbamazepine. The specific activity of phosphoglucomutase measured in vitro in erythrocytes from control subjects presented a normal distribution, with the difference between the lowest and the highest activity being approximately 2-fold (0.53-1.10 nmol mg Hb-1 min-1). Comparison of phosphoglucomutase activity in untreated bipolar patients and control subjects showed no significant difference, whereas comparison between bipolar patients treated with carbamazepine or lithium revealed significantly lower mean values in patients treated with carbamazepine (747.3 ± 27.6 vs 879.5 ± 35.9 pmol mg Hb-1 min-1, respectively). When we studied the concentration of lithium needed to inhibit phosphoglucomutase activity by 50 percent, a bimodal distribution among the population tested was obtained. The concentration of LiCl needed to inhibit phosphoglucomutase activity by 50 percent was 0.35 to 1.8 mM in one group of subjects and in the other it was 3 to 4 mM. These results suggest that phosphoglucomutase activity may be significant in patients with bipolar disorder treated with lithium and carbamazepine.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Antimaníacos/uso terapéutico , Trastorno Bipolar/tratamiento farmacológico , Carbamazepina/uso terapéutico , Eritrocitos/enzimología , Litio/uso terapéutico , Fosfoglucomutasa/efectos de los fármacos , Antimaníacos/farmacología , Escalas de Valoración Psiquiátrica Breve , Trastorno Bipolar/enzimología , Estudios de Casos y Controles , Carbamazepina/farmacología , Litio/farmacología , Fosfoglucomutasa/metabolismo
2.
Yi Chuan ; 26(5): 663-8, 2004 Sep.
Artículo en Chino | MEDLINE | ID: mdl-15640082

RESUMEN

Allozyme electrophoresis was employed to compare the difference in mortality among the genotypes at two polymorphic loci of Pgm and Me of grasshopper Oxya chinensis individuals acutely exposed to 1.5g/L malathion which resulted in 56% mortality in 24 hours. The selective lethal effects were observed among the genotypes at Pgm locus but not at Me locus. It is noted that the genotype Pgm-ab experienced the highest mortality (80%), whereas Pgm-bb and Pgm-bc were 49%, lower than the average. The chi(2) tests showed significant difference in morality between Pgm-bb and Pgm-cc. After exposure the allele frequency of Pgm-b showed a notable increase among surviving individuals. The cluster analysis based on Roger's genetic distance indicated that the acute exposure to malathion can cause differentiation in genetic composition at population level in Oxya chinensis. Because malathion is commonly used as the insecticide for grasshopper control, the data obtained in this study suggest that the similar genotype-mortality effects may occur in crop fields.


Asunto(s)
Saltamontes/efectos de los fármacos , Insecticidas/farmacología , Malatión/farmacología , Fosfoglucomutasa/genética , Polimorfismo Genético/efectos de los fármacos , Alelos , Animales , Análisis por Conglomerados , Frecuencia de los Genes , Variación Genética , Genética de Población , Genotipo , Saltamontes/clasificación , Saltamontes/enzimología , Saltamontes/genética , Malato Deshidrogenasa/efectos de los fármacos , Malato Deshidrogenasa/genética , Fosfoglucomutasa/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...